Files

Download

Download Full Text (396 KB)

Description

Introduction

  • Infusion-related reactions (IRRs) are well-known adverse drug reactions of many biological agents and antineoplastic medications
  • While typically mild-to-moderate in intensity, IRRs can be severe, with potentially life-threatening consequences requiring urgent interventions
  • Appropriate use of pre-treatment medications, such as corticosteroids, antihistamines, intravenous fluids, and antiemetics reduces the incidence and severity of IRRs

Purpose

  • Evaluate the use of pre-treatment medications in patients with experienced IRRs at an outpatient infusion center
  • Identify opportunities to improve treatment plans and reduce the occurrence of IRRs

Publication Date

2019

City

St. Cloud

Keywords

Infusion-related reactions, Anti-neoplastic agents, Immunologic dose-response relationship, Infusion center, Pre-treatment medications, Antineoplastic medications

Disciplines

Oncology | Other Pharmacy and Pharmaceutical Sciences

Comments

Poster presented at The American Society of Health-System Pharmacists Midyear Meeting, December 5-9, 2021; Virtual

Assessing the Use of Pre-Treatment Medications in the Management of Infusion-Related Reactions in an Outpatient Infusion Center

Share

COinS